CDDO-Me is more potent than CDDO in terms of its anticancer and cancer-preventive activities and ability to activate the Keap1/Nrf2/ARE pathway, which is involved in cytoprotection in the presence of excessive electrophiles or oxidative stress [14, 24]. The gene discussed is KEAP1; the disease is cancer.